The identity of these tumor-related pathways in CREM high expression group proved that the high expression of CREM in tumor and TME did change the characteristics of tumor, and the high expression of CREM in tumor tissues led to the activation of cancer-associated signaling pathways and poor prognosis. This evidence concerns the gene CREM and cancer.